The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
Open accessAbstract
siRNAs are a new class of therapeutic modalities with promising clinical efficacy that requires modification or formulation for delivery to the tissue and cell of interest. Conjugation of siRNAs to lipophilic groups supports efficient cellular uptake by a mechanism that is not well characterized. Here we study the mechanism of internalization of asymmetric, chemically stabilized, cholesterol-modified siRNAs (sd-rxRNAs®) that efficiently enter cells and tissues without the need for formulation. We demonstrate that uptake is rapid with significant membrane association within minutes of exposure followed by the formation of vesicular structures and internalization. Furthermore, sd-rxRNAs are internalized by a specific class of early endosomes and show preferential association with epidermal growth factor (EGF) but not transferrin (Tf) trafficking pathways as shown by live cell TIRF and structured illumination microscopy (SIM). In fixed cells, we observe ∼25% of sd-rxRNA co-localizing with EGF and <5% with Tf, which is indicative of selective endosomal sorting. Likewise, preferential sd-rxRNA co-localization was demonstrated with EEA1 but not RBSN-containing endosomes, consistent with preferential EGF-like trafficking through EEA1-containing endosomes. sd-rxRNA cellular uptake is a two-step process, with rapid membrane association followed by internalization through a selective, saturable subset of the endocytic process. However, the mechanistic role of EEA1 is not yet known. This method of visualization can be used to better understand the kinetics and mechanisms of hydrophobic siRNA cellular uptake and will assist in further optimization of these types of compounds for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intracellular distribution followed a perinuclear localization pattern that is characteristic of oligonucleotides11.”
From A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system (2019) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“Despite years of exploration, only a limited number of formulations and conjugates have progressed to the clinic: lipid nanoparticles (LNPs) (16,17), dynamic polyconjugates (18), dextrins (19), N-acetylgalactosamine (GalNAc) (8) and cholesterol (9).”
BackgroundDelivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast.
Vida, T. A., & Emr, S. D. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.5.779 · Cited by 1,364
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Gibbings, D., Ciaudo, C., Erhardt, M., & Voinnet, O. (2009) · Nature Cell Biology · doi:10.1038/ncb1929 · Cited by 1,037
Cited by
Sorted by citations
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138
Translation and functional roles of circular RNAs in human cancer
Lei, M., Zheng, G., Ning, Q., Zheng, J., & Dong, D. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1135-7 · Cited by 814
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 654
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
Wu, P., Mo, Y., Miao, P., Tang, T. F., Zhong, Y. M., Deng, X., Xiong, F., Guo, C. J., Wu, X., Li, Y., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1147-3 · Cited by 538
Gong, C., Tian, J., Wang, Z., Gao, Y., Wu, X., Ding, X., Qiang, L., Li, G., Han, Z., Yuan, Y., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0526-7 · Cited by 345
Changes in m6A RNA Methylation Contribute to Heart Failure Progression by Modulating Translation
Berulava, T., Buchholz, E., Vakhtang, E., Peña, T., Islam, R., Lbik, D., Mohamed, B. A., Renner, A., von Lewinski, D., Sacherer, M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1672 · Cited by 326
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
Brown, C. R., Gupta, S., Qin, J., Racie, T., He, G., Lentini, S., Malone, R., Yu, M., Matsuda, S., Shulga-Morskaya, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa670 · Cited by 285
Alterman, J. F., Godinho, B. M. D. C., Hassler, M. R., Ferguson, C. M., Echeverria, D., Sapp, E., Haraszti, R. A., Coles, A. H., Conroy, F., Miller, R., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0205-0 · Cited by 227
Self-citationCurrent Development of siRNA Bioconjugates: From Research to the Clinic
Chernikov, I. V., Vlassov, V. V., & Chernolovskaya, E. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00444 · Cited by 221
RNAi modulation of placental sFLT1 for the treatment of preeclampsia
Turanov, A. A., Lo, A. S., Hassler, M. R., Makris, A., Ashar-Patel, A., Alterman, J. F., Coles, A. H., Haraszti, R. Á., Roux, L., Godinho, B. M. D. C., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4297 · Cited by 217
Self-citationDiverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo
Biscans, A., Coles, A. H., Haraszti, R. Á., Echeverria, D., Hassler, M. R., Osborn, M. F., & Khvorova, A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1239 · Cited by 209
Self-citationvon Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S., Hickey, W. F., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0061-5 · Cited by 190
The new function of circRNA: translation
Shi, Y., Jia, X., & Xu, J. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02371-1 · Cited by 181
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
Hassler, M. R., Turanov, A. A., Alterman, J. F., Haraszti, R. A., Coles, A. H., Osborn, M. F., Echeverria, D., Nikan, M., Salomon, W. E., Roux, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky037 · Cited by 181
Self-citationEditorial focus: understanding off-target effects as the key to successful RNAi therapy
Bartoszewski, R., & Sikorski, A. F. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0196-3 · Cited by 157
The regulation of protein translation and its implications for cancer
Song, P., Yang, F., Jin, H., & Wang, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00444-9 · Cited by 144
Improving siRNA Delivery In Vivo Through Lipid Conjugation
Osborn, M. F., & Khvorova, A. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0725 · Cited by 137
Self-citation5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo
Haraszti, R. Á., Roux, L., Coles, A. H., Turanov, A. A., Alterman, J. F., Echeverria, D., Godinho, B. M. D. C., D, N. A. M., & Khvorova, A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx507 · Cited by 129
Self-citationIntracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano, R. L. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0727 · Cited by 125
Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells
Zhang, J., Gan, Y., Li, H., Yin, J., He, X., Lin, L., Xu, S., Fang, Z., Kim, B.-W., Gao, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30264-0 · Cited by 120
Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles
Haraszti, R. A., Miller, R., Didiot, M.-C., Biscans, A., Alterman, J. F., Hassler, M. R., Roux, L., Echeverria, D., Sapp, E., DiFiglia, M., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.024 · Cited by 107
Self-citationCurrent Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
Tai, W. (2019) · Molecules · doi:10.3390/molecules24122211 · Cited by 97
Wu, S., Zhang, A., Li, S., Chatterjee, S., Qi, R., Segura-Ibarra, V., Mauro Ferrari, B., Gupte, A. A., Blanco, E., & Hamilton, D. J. (2018) · Advanced Science · doi:10.1002/advs.201700530 · Cited by 96
A molecular network of conserved factors keeps ribosomes dormant in the egg
Leesch, F., Lorenzo‐Orts, L., Pribitzer, C., Grishkovskaya, I., Roehsner, J., Chugunova, A. A., Matzinger, M., Roitinger, E., Belačić, K., Kandolf, S., et al. (2023) · Nature · doi:10.1038/s41586-022-05623-y · Cited by 92
Malik, N., Yan, H., Moshkovich, N., Palangat, M., Yang, H. H., Sanchez, V. C., Cai, Z., Peat, T. J., Jiang, S., Liu, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10102-6 · Cited by 81
Biscans, A., Caiazzi, J., Davis, S. M., McHugh, N., Sousa, J., & Khvorova, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa595 · Cited by 69
Self-citationMechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice
Chappell, A. E., Gaus, H. J., Berdeja, A., Gupta, R., Jo, M., Prakash, T. P., Oestergaard, M. E., Swayze, E. E., & Seth, P. P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa164 · Cited by 76
Shmushkovich, T., Monopoli, K. R., Homsy, D., Leyfer, D., Betancur-Boissel, M., Khvorova, A., & Wolfson, A. D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky745 · Cited by 69
Self-citationNon-viral nanoparticles for RNA interference: Principles of design and practical guidelines
Liu, Z., Wang, S., Tapeinos, C., Torrieri, G., Känkänen, V., El‐Sayed, N., Python, A., Hirvonen, J. J., & Santos, H. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.018 · Cited by 73
Biscans, A., Coles, A. H., Echeverria, D., & Khvorova, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.028 · Cited by 61
Self-citationChemical optimization of siRNA for safe and efficient silencing of placental sFLT1
Davis, S. M., Hariharan, V. N., Lo, A. S., Turanov, A. A., Echeverria, D., Sousa, J., McHugh, N., Biscans, A., Alterman, J. F., Karumanchi, S. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.009 · Cited by 61
Self-citationSegal, M., Biscans, A., Gilles, M.-E., Anastasiadou, E., Luca, R. D., Lim, J., Khvorova, A., & Slack, F. J. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.008 · Cited by 58
Self-citationALKBH3-dependent m1A demethylation of Aurora A mRNA inhibits ciliogenesis
Kuang, W., Jin, H., Yang, F., Chen, X., Liu, J., Li, T., Chang, Y., Liu, M., Xu, Z., Huo, C., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00385-3 · Cited by 58
Biscans, A., Haraszti, R. Á., Echeverria, D., Miller, R., Didiot, M.-C., Nikan, M., Roux, L., D, N. A. M., & Khvorova, A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.019 · Cited by 57
Self-citationLigtenberg, M. A., de Coaña, Y. P., Shmushkovich, T., Yoshimoto, Y., Truxová, I., Yang, Y., Betancur-Boissel, M., Eliseev, A. V., Wolfson, A. D., & Kiessling, R. W. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.015 · Cited by 53
Godinho, B. M. D. C., Gilbert, J. W., Haraszti, R. A., Coles, A. H., Biscans, A., Roux, L., Nikan, M., Echeverria, D., Hassler, M., & Khvorova, A. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0690 · Cited by 52
Self-citationModulating intracellular pathways to improve non-viral delivery of RNA therapeutics
de Vyver, T. V., Smedt, S. C. D., & Raemdonck, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114041 · Cited by 51
Conroy, F., Miller, R., Alterman, J. F., Hassler, M. R., Echeverria, D., Godinho, B. M. D. C., Knox, E. G., Sapp, E., Sousa, J., Yamada, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33061-x · Cited by 47
Self-citationOptimized delivery of siRNA into 3D tumor spheroid cultures in situ
Morgan, R. G., Chambers, A. C., Legge, D. N., Coles, S. J., Greenhough, A., & Williams, A. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-26253-3 · Cited by 47
Liu, W., Iwamoto, N., Marappan, S., Luu, K., Tripathi, S., Purcell-Estabrook, E., Shelke, J. D., Shah, H., Lamattina, A., Pan, Q., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad268 · Cited by 44
Chemical modulation of siRNA lipophilicity for efficient delivery
Tai, W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.022 · Cited by 45
Shen, P., Reineke, L. C., Knutsen, E., Chen, M., Pichler, M., Ling, H. Y., & Călin, G. A. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12384 · Cited by 42
Massaro, C., Sgueglia, G., Frattolillo, V., Baglio, S. R., Altucci, L., & Dell’Aversana, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100980 · Cited by 44
Ly, S., Echeverria, D., Sousa, J., & Khvorova, A. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.029 · Cited by 38
Self-citationTranslation regulation in response to stress
Williams, T. D., & Rousseau, A. (2024) · FEBS Journal · doi:10.1111/febs.17076 · Cited by 45
The ice age – A review on formulation of Adeno-associated virus therapeutics
Grossen, P., Skaripa-Koukelli, I., van Haasteren, J., Machado, A. H. E., & Dürr, C. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.07.002 · Cited by 41
Lacroix, A., Fakih, H. H., & Sleiman, H. F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.020 · Cited by 39
Noncovalent tagging of siRNA with steroids for transmembrane delivery
Tai, W., & Gao, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.007 · Cited by 34
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
Ferguson, C. M., Echeverria, D., Hassler, M. R., Ly, S., & Khvorova, A. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.006 · Cited by 34
Self-citationJuliano, R. L. (2021) · Biomedicines · doi:10.3390/biomedicines9050512 · Cited by 34
Fàbrega, C., Aviñó, A. M., Navarro, N., Jorge, A. F., Grijalvo, S., & Eritja, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020320 · Cited by 34
Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules
Hawner, M., & Ducho, C. (2020) · Molecules · doi:10.3390/molecules25245963 · Cited by 31
PUS7‐dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression
Chang, Y., Jin, H., Cui, Y., Yang, F., Chen, K., Kuang, W., Huo, C., Xu, Z., Li, Y., Lin, A., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1811 · Cited by 30
Cyclic peptide-based nanostructures as efficient siRNA carriers
Panigrahi, B., Singh, R. K., Mishra, S., & Mandal, D. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1511574 · Cited by 32
RNAi-based modulation of IFN-γ signaling in skin
Tang, Q., Sousa, J., Echeverria, D., Fan, X., Hsueh, Y.-C., Afshari, K., MeHugh, N., Cooper, D., Vangjeli, L., Monopoli, K. R., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.019 · Cited by 30
Self-citationModulation of PDCD1 exon 3 splicing
Sun, J., Bai, J., Jiang, T., Gao, Y., & Hua, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1659080 · Cited by 30
Rpl12 is a conserved ribophagy receptor
Chen, Y., Hu, J., Zhao, P., Fang, J., Kuang, Y., Liu, Z., Dong, S., Yao, W., Ding, Y., Wang, X., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01598-2 · Cited by 29
Zhao, L., Wang, L., Zhang, C., Liu, Z., Piao, Y., Yan, J., Xiang, R., Yao, Y., & Shi, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0060-y · Cited by 28
Monty, M. A., Islam, M. A., Xu, N., Tan, J., Tuhin, I. J., Tang, X., Miao, M., Wu, D., & Yu, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15414 · Cited by 31
Nucleic acid amphiphiles: Synthesis, properties, and applications
Gubu, A., Zhang, X., Lü, A., Zhang, B., Ma, Y., & Zhang, G. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.022 · Cited by 30
Monopoli, K. R., Korkin, D., & Khvorova, A. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.010 · Cited by 27
Self-citationInsight into the siRNA transmembrane delivery—From cholesterol conjugating to tagging
Zheng, Y., & Tai, W. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1606 · Cited by 28
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy
Davis, S. M., Hildebrand, S. R., MacMillan, H. J., Monopoli, K. R., Buchwald, J. E., Sousa, J., Cooper, D., Ly, S., Echeverria, D., McHugh, N., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf479 · Cited by 26
Self-citationMaguregui, A., & Abe, H. (2020) · ChemBioChem · doi:10.1002/cbic.202000009 · Cited by 26
Davis, S. M., Sousa, J., Vangjeli, L., Hassler, M. R., Echeverria, D., Knox, E. G., Turanov, A. A., Alterman, J. F., & Khvorova, A. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.05.010 · Cited by 23
Self-citationKB343, a Cyclic Tris-guanidine Alkaloid from Palauan ZoantharianEpizoanthus illoricatus
Matsumura, K., Taniguchi, T., Reimer, J. D., Noguchi, S., Fujita, M., & Sakai, R. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b01069 · Cited by 22
Park, Y., Koga, Y., Su, C., Waterbury, A. L., Johnny, C. L., & Liau, B. B. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901386 · Cited by 24
Comprehensive discovery and functional characterization of the noncanonical proteome
Shi, C., Liu, F., Su, X., Yang, Z., Wang, Y., Xie, S., Xie, S., Sun, Q., Chen, Y., Sang, L., et al. (2025) · Cell Research · doi:10.1038/s41422-024-01059-3 · Cited by 21
Ohmer, M., Tzivelekidis, T., Niedenführ, N., Volceanov, L., Barth, S., Vier, J., Börries, M., Busch, H. S., Kook, L., Biniossek, M. L., et al. (2018) · Cellular Microbiology · doi:10.1111/cmi.12993 · Cited by 21
Loading of Extracellular Vesicles with Hydrophobically Modified siRNAs
Didiot, M.-C., Haraszti, R. Á., D, N. A. M., & Khvorova, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7652-2_16 · Cited by 20
Self-citationTransport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics
Markov, O. V., Filatov, A. V., Kupryushkin, M. S., Chernikov, I. V., Patutina, O., Strunov, A. A., Chernolovskaya, E. L., Vlassov, V. V., Pyshnyi, D. V., & Аркадьевна, З. М. (2020) · Molecules · doi:10.3390/molecules25163663 · Cited by 20
Yamada, K., Hildebrand, S. R., Davis, S. M., Miller, R., Conroy, F., Sapp, E., Caiazzi, J., Alterman, J. F., Roux, L., Echeverria, D., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1126 · Cited by 19
Self-citationBerk, C., Civenni, G., Wang, Y., Steuer, C., Catapano, C. V., & Hall, J. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0852 · Cited by 19
Fluorocarbons Enhance Intracellular Delivery of Short STAT3-sensors and Enable Specific Imaging
Metelev, V., Zhang, S., Zheng, S., Kumar, A. T. N., & Bogdanov, A. A., Jr. (2017) · Theranostics · doi:10.7150/thno.19704 · Cited by 19
Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism
Makwana, K., Gosai, N., Poe, A., & Kondratov, R. V. (2018) · The FASEB Journal · doi:10.1096/fj.201802167r · Cited by 18
Systemic Delivery of Small Interfering RNA Therapeutics: Obstacles and Advances
Chandela, A., & Ueno, Y. (2019) · Reviews in Agricultural Science · doi:10.7831/ras.7.10 · Cited by 19
Control of translation during the unfolded protein response in maize seedlings: Life without PERKs
Kanodia, P., Vijayapalani, P., Srivastava, R., Bi, R., Liu, P., Miller, W. A., & Howell, S. H. (2020) · Plant Direct · doi:10.1002/pld3.241 · Cited by 18
Cheng, S.-Y., Caiazzi, J., Biscans, A., Alterman, J. F., Echeverria, D., McHugh, N., Hassler, M. R., Jolly, S. M., Giguere, D., Cipi, J., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102088 · Cited by 20
Self-citationStrategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs
Lindner, S., Keim, S., Haddadzadegan, S., Romero, O. F., Zöller, K., Stern, G., Cesi, I., Kafedjiiski, K., & Bernkop‐Schnürch, A. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503721 · Cited by 20
Chernikov, I. V., Gladkikh, D. V., Meschaninova, M. I., Karelina, U. A., Venyaminova, A. G., Аркадьевна, З. М., Vlassov, V. V., & Chernolovskaya, E. L. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0745 · Cited by 17
Biomimetic Dextran–Peptide Vectors for Efficient and Safe siRNA Delivery
Qu, X., Hu, Y., Wang, H.-F., Song, H., Young, M. A., Xu, F., Liu, Y., & Cheng, G. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00714 · Cited by 15
Wang, Q., & Mao, Y. (2023) · Advanced Biotechnology · doi:10.1007/s44307-023-00006-4 · Cited by 15
Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer
Muntean, C., Blondeel, E., Harinck, L., Pednekar, K. P., Prakash, J., Wever, O. D., Chain, J. L., Smedt, S. C. D., Remaut, K., & Raemdonck, K. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123348 · Cited by 13
Hernández, R. B., Moteshareie, H., Burnside, D. J., McKay, B. C., & Golshani, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-42907-2 · Cited by 12
Aptamer-incorporated DNA Holliday junction for the targeted delivery of siRNA
Jeong, E. H., Jeong, H., Jang, B., Kim, B. Y., Kim, M., Kwon, H., Lee, K., & Lee, H. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.07.025 · Cited by 12
Xue, M.-G., Cong, F., Zheng, W.-L., Xu, R.-Q., Liu, X., Bao, H., Sung, Y., Xi, Y.-M., He, F., Ma, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01587-8 · Cited by 12
Cholesterol Conjugates of Small Interfering RNA: Linkers and Patterns of Modification
Chernikov, I. V., Ponomareva, U. A., Meschaninova, M. I., Bachkova, I. K., Vlassov, V. V., Аркадьевна, З. М., & Chernolovskaya, E. L. (2024) · Molecules · doi:10.3390/molecules29040786 · Cited by 10
Important Aspects of siRNA Design for Optimal Efficacy In Vitro and In Vivo
Bhakta-Yadav, M. S., & Brown, T. L. (2025) · International Journal of Cell Biology · doi:10.1155/ijcb/6663816 · Cited by 11
Akçaöz-Alasar, A., Tüncel, Ö., Sağlam, B., Gazaloğlu, Y., Atbinek, M., Cagiral, U., İşcan, E., Özhan, G., & Akgül, B. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31176 · Cited by 10
Haraszti, R. Á., Coles, A. H., D, N. A. M., Khvorova, A., & Didiot, M.-C. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2338 · Cited by 10
Self-citationIdentification of selective and non-selective C9ORF72 targeting in vivo active siRNAs
Gilbert, J. W., Kennedy, Z., Godinho, B. M. D. C., Summers, A., Weiss, A., Echeverria, D., Bramato, B. M., McHugh, N., Cooper, D., Yamada, K., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102291 · Cited by 8
Self-citationMethods for Evaluating the Stimuli-Responsive Delivery of Nucleic Acid and Gene Medicines
Fumoto, S., & Nishida, K. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00096 · Cited by 8
Alterman, J. F., Coles, A. H., Hall, L. M., D, N. A. M., Khvorova, A., & Didiot, M.-C. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2501 · Cited by 9
Self-citationRules and impacts of nonsense‐mediated mRNA decay in the degradation of long noncoding RNAs
Singh, A. K. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1853 · Cited by 8
The Medicinal Chemistry of Antisense Oligonucleotides
Watts, J. K. (2018) · Wiley eBooks · doi:10.1002/9781119070153.ch2 · Cited by 8
Cuiffo, B., Maxwell, M., Yan, D., Guemiri, R., Boone, A., Bellet, D., Rivest, B., Cardia, J. P., Robert, C., & Fricker, S. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1501679 · Cited by 8
Self-citationChemical Modifications in Nucleic Acid Therapeutics
Lennox, K. A., Young, R. C., & Behlke, M. A. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4742-4_3 · Cited by 8
Kajino, R., Sakamoto, S., & Ueno, Y. (2022) · RSC Advances · doi:10.1039/d2ra00705c · Cited by 7
Maxwell, M., Yan, D., Rivest, B., Boone, A., Cardia, J. P., & Noeßner, E. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03835-x · Cited by 7
Self-citation
Metadata
- Authors
- Ly, S., Navaroli, D. M., Didiot, M.-C., Cardia, J., Pandarinathan, L., Alterman, J. F., Fogarty, K., Standley, C., Lifshitz, L. M., Bellve, K. D., Prot, M., Echeverria, D., Corvera, S., & Khvorova, A.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Phio Pharmaceuticals (United States) (US)
- Corresponding author
- Khvorova, Anastasia
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-28
- Volume
- 45
- Issue
- 1
- Pages
- 15-25
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5224471
- OpenAlex
- W2557242880
- Cited by
- 132
- References
- 83
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 9 · 2021: 9 · 2020: 19 · 2019: 22 · 2018: 21 · 2017: 8
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by)
- HighWire Press Open Archive (submittedVersion)
- Funders
- University of Massachusetts (DK32520)
- University of Oxford
- National Institutes of Health (1s10od020012-01)
- National Institute of General Medical Sciences (R01GM108803, R25GM113686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- siRNA delivery, cellular uptake, endocytosis, early endosomes, transferrin receptor, EEA1, membrane association
- MeSH terms
- Animals, Biological Transport, Chlorocebus aethiops, Cholesterol, Endocytosis, Epidermal Growth Factor, HeLa Cells, Humans, Microscopy, Fluorescence, Endosomes, Transferrin, Gene Expression, COS Cells, Cyclophilins, Vesicular Transport Proteins, RNA, Small Interfering, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review